{
    "clinical_study": {
        "@rank": "100955", 
        "acronym": "Aquadex", 
        "brief_summary": {
            "textblock": "The number of patients with acute congestion on chronic heart failure is increasing.\n      Ultrafiltration has recently been proposed as an alternative approach for the stabilization\n      of volume balance, especially in patients with imminent diuretic resistance.\n\n      There is increasing evidence that ultrafiltration may relief cardiac congestion with lesser\n      effects on blood pressure and activation of renin angiotensin system, respectively .\n      However, recent studies revealed conflicting results: demonstration the superiority of\n      ultrafiltration in comparison to diuretic treatment, and a lack of evidence of benefit, as\n      well as an excess of adverse events with ultrafiltration.\n\n      Aquapheresis with adapted ultrafiltration rate guided by central venous pressure is safer\n      than aquaphesis with a constant ultrafiltration with comparable effectiveness"
        }, 
        "brief_title": "CVP-guided Aquapheresis for the Treatment of Acute Congestion in Heart Failure", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Heart Failure", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with chronic heart failure scheduled for LVAD\n\n          -  Indication for CVVH/Aquapheresis\n\n        Exclusion Criteria:\n\n          -  Renal Disease (GFR <20 ml / min)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with chronic heart failure listed for LVAD"
            }
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02079259", 
            "org_study_id": "Aquadex"
        }, 
        "intervention": {
            "intervention_name": "Ultrafiltration", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 4, 2014", 
        "link": {
            "url": "http://www.uniklinik-duesseldorf.de/Kardiologie"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Duesseldorf", 
                    "country": "Germany"
                }, 
                "name": "Division of Cardiology, Pulmonary Diseases, Vascular Medicine, University Hospital Dusseldorf"
            }, 
            "investigator": [
                {
                    "last_name": "Stefanie Keymel, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Ralf Westenfeld, MD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "official_title": "CVP-guided Aquapheresis for the Treatment of Acute Congestion in Heart Failure - A Pilot Study to Optimize Individualized Volume Depletion", 
        "overall_contact": {
            "email": "ralf.westenfeld@med.uni-duesseldorf.de", 
            "last_name": "Ralf Westenfeld, MD"
        }, 
        "overall_contact_backup": {
            "email": "rabea.wagstaff@med.uni-duesseldorf.de", 
            "last_name": "Rabea Wagstaff, B.Sc., M.A."
        }, 
        "overall_official": [
            {
                "affiliation": "Division of Cardiology, Pulmonary Diseases, Vascular Medicine, University Hospital Dusseldorf", 
                "last_name": "Ralf Westenfeld, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Division of Cardiology, Pulmonary Diseases, Vascular Medicine, University Hospital Dusseldorf", 
                "last_name": "Malte Kelm, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Changes in central venous pressure", 
            "safety_issue": "No", 
            "time_frame": "Changes from Baseline to 48 h after intervention"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02079259"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Heinrich-Heine University, Duesseldorf", 
            "investigator_full_name": "Klinik f\u00fcr Kardiologie, Pneumologie und Angiologie", 
            "investigator_title": "Klinik f\u00fcr Kardiologie, Pneumologie und Angiologie", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "amount of net fluid loss", 
                "safety_issue": "No", 
                "time_frame": "48 h"
            }, 
            {
                "measure": "Measure of dyspnea using a visual analog scale", 
                "safety_issue": "No", 
                "time_frame": "Changes from Baseline to 48 h after intervention"
            }, 
            {
                "description": "right/left heart function measured by Echocardiography and BNP (Brain Natriuretic Peptide)", 
                "measure": "heart function", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }, 
            {
                "description": "GFR, Cystatin C, HCO3-, NT-proBNP, CK, Troponin, Hematocrit", 
                "measure": "Biomarker", 
                "safety_issue": "Yes", 
                "time_frame": "Changes from Baseline to 48 h after intervention"
            }, 
            {
                "measure": "Time until impaired plasma refill rate", 
                "safety_issue": "No", 
                "time_frame": "48 h"
            }, 
            {
                "measure": "blood pressure", 
                "safety_issue": "No", 
                "time_frame": "Changes from Baseline to 48 h after intervention"
            }, 
            {
                "measure": "heart rate", 
                "safety_issue": "No", 
                "time_frame": "Changes from Baseline to 48 h after intervention"
            }, 
            {
                "measure": "Serum Creatinine level", 
                "safety_issue": "Yes", 
                "time_frame": "48 h"
            }
        ], 
        "source": "Heinrich-Heine University, Duesseldorf", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Heinrich-Heine University, Duesseldorf", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}